CAQK peptide

CAQK peptide selectively binds to injured mouse brain. CAQK peptide selectively targets demyelinating areas and it is absent from healthy tissue. The CAQK peptide target is a proteoglycan complex upregulated in brain injuries and is used for drug delivery. CAQK peptide can penetrate the blood-brain barrier.


Cat. No.: EX-A13556	Purity: >98%

	Chemical structure of CAQK peptide

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock	Quantity	Order
100mg	get quote
1g	get quote

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	Cys-Ala-Glu-Lys
CAS No.	2088281-24-5
Purity	>98%
Formula	C17H32N6O6S
Mol Weight	448.538
Color	White to off-white
State	Solid
Solubility	H2O : ? 100 mg/mL DMSO : ? 100 mg/mL
Shelf Life	>2 years if stored properly
Storage	Powder 80°C, 2 years , -20°C, 1 year, Sealed storage, away from moisture; In solvent -20°C, 1 month.
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Charly Abi-Ghanem, et al. CAQK, a peptide associating with extracellular matrix components targets sites of demyelinating injuries. Front Cell Neurosci. 2022 Aug 22:16:908401. [2]. Aman P Mann, et al. A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries. Nat Commun. 2016 Jun 28:7:11980.
CoA	CoA of CAQK peptide

Smiles:	[C@H](C(N[C@@H](CCCCN)C(O)=O)=O)(NC([C@@H](NC([C@H](CS)N)=O)C)=O)CCC(N)=O


		Search